Cartalax (20 mg)

Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.

Cartalax Structure
Amino Acid Sequence: Ala-Glu-Asp (AED)
Molecular Formula: C₁2H19N3O8
Molecular Weight: 333.29 g/mol
PubChem CID: 87815447
Synonyms: T-31, AED, SCHEMBL5324601, Alanyl-glutamyl-aspartic acid

Image Checkout
Guaranteed Checkout
Categories: ,
Want a discount? Become a member!

Cartalax, a concise peptide possessing bioregulatory characteristics, primarily influences fibroblasts, pervasive cells present in diverse tissues ranging from cartilage to skin, blood vessels, and the kidneys. Studies suggest that Cartalax modulates cell proliferation and apoptosis via multiple molecular pathways, such as elevating Ki-67 levels, diminishing p53 signaling, and triggering NF-KB signaling. Categorized as an anti-aging bioregulator, Cartalax diminishes senescence, rejuvenates older cells, and seemingly decelerates the general aging process within tissues.